CN104383470A - Traditional Chinese medicine for treating lung yin deficiency syndrome type lung disease - Google Patents

Traditional Chinese medicine for treating lung yin deficiency syndrome type lung disease Download PDF

Info

Publication number
CN104383470A
CN104383470A CN201410556312.0A CN201410556312A CN104383470A CN 104383470 A CN104383470 A CN 104383470A CN 201410556312 A CN201410556312 A CN 201410556312A CN 104383470 A CN104383470 A CN 104383470A
Authority
CN
China
Prior art keywords
parts
lung
chinese medicine
grams
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410556312.0A
Other languages
Chinese (zh)
Inventor
刘淑平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Xiangxiang Biological Pharmaceutical Co Ltd
Original Assignee
Qingdao Xiangxiang Biological Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Xiangxiang Biological Pharmaceutical Co Ltd filed Critical Qingdao Xiangxiang Biological Pharmaceutical Co Ltd
Priority to CN201410556312.0A priority Critical patent/CN104383470A/en
Publication of CN104383470A publication Critical patent/CN104383470A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating a lung yin deficiency syndrome type lung disease. The traditional Chinese medicine is characterized by comprising, by weight, 25-30 parts of fresh ginger, 15-20 parts of bamboo juice, 25-30 parts of radish, 25-30 parts of granulated sugar, 3-5 parts of borax, 10-12 parts of subprostrate sophora, 15-20 parts of flos farfarae, 8-10 parts of golden cypress, 12-15 parts of radix scrophulariae, 15-20 parts of common hogfennei root, 25-30 parts of schisandra chinensis, 25-30 parts of colla corii asini and 25-30 parts of black soya beans. According to the traditional Chinese medicine, as the various raw materials are organically combined together, and the ingredients are coordinated and interacted with each other, both symptoms and root causes of the lung yin deficiency syndrome type lung disease can be treated, and the good conditioning effect on the body can be achieved. Over the years, follow-up survey statistics on 100 patients with the lung yin deficiency syndrome type lung disease can show that the effective rate of the prescription reaches 100%; the obviously-effective rate of the prescription reaches 100%; and the cure rate of the prescription reaches 96%.

Description

A kind of Chinese medicine for the treatment of deficiency of lung-YIN pattern of syndrome pneumonopathy
 
Technical field the present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of deficiency of lung-YIN pattern of syndrome pneumonopathy.
Background technology lung occupies in the heart, upper even air flue, throat, and have one's ideas straightened out in nose, be collectively referred to as lung system, its major function is main gas, and department breathes with the exchange of the pure and impure gas of row, participates in the generation of pectoral qi, concentrate heart arteries and veins on to run whole body, and main a surname falls, regulating fluid apssage.Pneumonopathy is mainly reflected in lung system, respiratory function hypopraxia, and the defeated cloth of water liquid metabolism is not normal, and defends the aspects such as outer function dereliction of duty, its Symptoms with cough, dyspnea with rapid and short breath, cough up phlegm, chest pain, larynx pain, sound variation, nasal obstruction watery nasal discharge, edema etc. be for common.The syndrome of pneumonopathy comprises the polytypes such as syndrome of deficiency of lung yin, syndrome of dryness invading lung, syndrome of exuberance of lung heat, syndrome of phlegm-heat obstructing lung, syndrome of fluid retained in chest and hypochondrium, syndrome of fighting of wind with water.What the present invention mainly studied is clinical common deficiency of lung-YIN pattern of syndrome pneumonopathy, this pattern of syndrome system lack of lung-YIN, loses in respectful clearly, the raw syndrome showed in deficiency-heat, many because of dryness-heat impairing the lung, or consumptive disease worm-eaten lung, consumption impairing the lung is cloudy, or sweating impairment of body fluid, cloudy Tianjin consumption is let out, or chronic cough is not healed, consume lung yin, gradually causes lung yin virtual loss and forms.Theory of Chinese medical science is thought, lung being a delicate viscus, and property happiness is clear and rich, and post is respectful clearly, lack of lung-YIN, the raw lung that burns in deficiency-heat, so that the scorehed lung-lobe due to lung-heat, lose in respectful clearly, QI rising in reverse order is in upper, therefore dry cough without phlegm, or expectorant is few and sticky, be difficult to bring up, very then asthenic fire is burnt lung network, and network blood trouble is overflow, then sputum mixed with blood.Lack of lung-YIN, throat loses profit, and is steamed by asthenic fire, so that hoarseness.Deficiency of YIN sun is without made, vehement in deficiency-heat, thus hectic fever in the afternoon, dysphoria with feverish sensation in the chest palms and soles; Heat disturbs battalion's the moon then night sweat; Hyperactivity of deficient fire, therefore two cheekbones are rubescent; YIN-fluid being insufficient, loses in nourishing, then dryness of the mouth and throat, emaciated physique, and has the symptom such as red tongue with a little fluid, thready and rapid pulse.At present, this disease of western medical treatment is cured the symptoms, not the disease, and side effect is very big, and easily forms dependency.
Summary of the invention the object of the invention is the Therapeutic Principle according to " nourishing YIN and moistening the lung, nourishing kidney are strengthened water, fallen deficiency-heat, relieving cough and resolving phlegm clearly ", a kind of Chinese medicine treating deficiency of lung-YIN pattern of syndrome pneumonopathy is provided, this Chinese medicine is adopted not only to cure speed fast, more no longer recur after, and without any side effects, also have good opsonic action to healthy.
For realizing above-mentioned purpose of the present invention, the technical scheme adopted is: a kind of Chinese medicine for the treatment of deficiency of lung-YIN pattern of syndrome pneumonopathy, is characterized in that the Chinese medicine preparation be made up of the medical material of following weight proportion: 25-30 parts, Rhizoma Zingiberis Recens, Succus Bambusae 15-20 parts, Radix Raphani 25-30 parts, Saccharum Sinensis Roxb. 25-30 parts, Borax 3-5 parts, Radix Sophorae Tonkinensis 10-12 parts, Flos Farfarae 15-20 parts, Cortex Phellodendri 8-10 parts, Radix Scrophulariae 12-15 parts, Radix Peucedani 15-20 parts, Fructus Schisandrae Chinensis 25-30 parts, 25-30 parts, Colla Corii Asini, 25-30 parts, Semen sojae atricolor.Processing technique of the present invention is: various medical material grinding is become end, then uses conventional method " whole part " to extract and makes instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserves in shady and cool, dry place.Dissolve with boiled water after meal and take, have part insoluble matter to be normal phenomenon, under all taking after mixing, twice on the one (morning and evening is each once), each one bag 7 days is a course for the treatment of.Period in a medicine, avoids tobacco and wine, raw meat, cold, peppery, greasy food, and keep good work and rest custom, association rationally reduces pressure, and actively participates in outdoor activity, loosens mood, avoid staying up late as far as possible.
Rhizoma Zingiberis Recens of the present invention has effect of preventing phlegm from forming and stopping coughing, relieving the exterior syndrome by diaphoresis; The Succus Bambusae adopted has effect of the sliding expectorant of heat clearing away, relieving convulsion sharp key; The Radix Raphani adopted has effect of heat of reducing phlegm, the therapeutic method to keep the adverse QI flowing downwards, alleviating distention in middle-JIAO; The Saccharum Sinensis Roxb. adopted has effect of the lung moistening and production of body fluid promoting, cough-relieving and middle lung benefiting, irritability of releiving, YIN nourishing; The Borax adopted has effect of removing heat from the lung and dissipating phlegm; The Radix Sophorae Tonkinensis adopted has relieving inflammation or internal heat, detoxifies, subsides a swelling, effect of pain relieving; The Flos Farfarae adopted has nourishing the lung to keep the adverse QI downward, the effect of the antitussive that reduces phlegm; The Cortex Phellodendri adopted has effect of heat clearing away, dampness, pathogenic fire purging, removing toxic substances; The Radix Scrophulariae adopted has effect of tonifying kidney-yin, resolving heat and reducing pathogenic fire, detoxicating and resolving stagnation of pathogens; Radix Peucedani is adopted to have effect of dispelling wind-heat, the therapeutic method to keep the adverse QI flowing downwards, expectorant; Adopt Fructus Schisandrae Chinensis have astringe the lung, nourishing kidney, promote the production of body fluid, receive antiperspirant, arresting seminal emission, kidney tonic liquid effect; The Colla Corii Asini adopted has effect of tonifying the lung the moon; The Semen sojae atricolor adopted has effect of the kidney invigorating paddy, diuretic gas.Above various raw material is organically combined by the present invention, mutually coordinates between each composition, interacts, can treating both the principal and secondary aspects of a disease to deficiency of lung-YIN pattern of syndrome pneumonopathy, and has good opsonic action to health.For many years, by the follow-up investigation statistics to 100 these type of patients of example, show that this prescription effective percentage reaches 100%, obvious effective rate reaches 100%, and cure rate reaches 96%.Below by the basic condition analysis to relevant data, further illustrate effect of the present invention.
Table one: general patient demographic's structure situation
Table two: curative effect situation
Enumerate three model cases below and further illustrate effect of the present invention:
1, Lin, man, birth in 1974, when 35 years old, occur dry cough few expectorant, not easily expectoration, the symptoms such as dryness of the mouth and throat, without organic disease, after 2 months, are diagnosed as deficiency of lung-YIN pattern of syndrome pneumonopathy in here.After taking 1 course for the treatment of of this prescription, remission, after taking 2 courses for the treatment of, symptom is clearly better, rear continue to take consolidate 1 course for the treatment of after, symptom disappears entirely, recovery from illness.
2, model, man, birth in 1967, when 43 years old, the symptoms such as appearance is coughed, expectorant is few and sticky, dysphoria with feverish sensation in the chest palms and soles, night sweat, flushed cheeks, without organic disease, after 3 months, deficiency of lung-YIN pattern of syndrome pneumonopathy is diagnosed as in here, after taking 1 course for the treatment of of this prescription, symptom is alleviated to some extent, and after 2 courses for the treatment of, symptom is obviously alleviated, after continuing to take 2 courses for the treatment of, symptom disappears entirely, recovery from illness.
3, Lee, man, birth in 1980, when 30 years old, there is the symptoms such as dry cough few expectorant, sputum mixed with blood, hoarseness, red tongue with a little fluid, thready and rapid pulse, without organic disease, after 2 months, be diagnosed as deficiency of lung-YIN pattern of syndrome pneumonopathy in here, after taking 1 course for the treatment of of this prescription, symptom is obviously alleviated, after 2 courses for the treatment of, symptom disappears substantially, after continue again to take 2 courses for the treatment of and consolidate, symptom disappears entirely, recovery from illness.
Detailed description of the invention, for describing the present invention in detail, does further detailed description below in conjunction with specific embodiment to the present invention.
Embodiment 1: 25 grams, Rhizoma Zingiberis Recens, Succus Bambusae 15 grams, Radix Raphani 25 grams, Saccharum Sinensis Roxb. 25 grams, Borax 3 grams, Radix Sophorae Tonkinensis 10 grams, Flos Farfarae 15 grams, Cortex Phellodendri 8 grams, Radix Scrophulariae 12 grams, Radix Peucedani 15 grams, Fructus Schisandrae Chinensis 25 grams, 25 grams, Colla Corii Asini, 25 grams, Semen sojae atricolor.Above various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.
Embodiment 2: 28 grams, Rhizoma Zingiberis Recens, Succus Bambusae 18 grams, Radix Raphani 28 grams, Saccharum Sinensis Roxb. 28 grams, Borax 4 grams, Radix Sophorae Tonkinensis 11 grams, Flos Farfarae 18 grams, Cortex Phellodendri 9 grams, Radix Scrophulariae 14 grams, Radix Peucedani 18 grams, Fructus Schisandrae Chinensis 28 grams, 28 grams, Colla Corii Asini, 28 grams, Semen sojae atricolor.Above various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.
Embodiment 3: 30 grams, Rhizoma Zingiberis Recens, Succus Bambusae 20 grams, Radix Raphani 30 grams, Saccharum Sinensis Roxb. 30 grams, Borax 5 grams, Radix Sophorae Tonkinensis 12 grams, Flos Farfarae 20 grams, Cortex Phellodendri 10 grams, Radix Scrophulariae 15 grams, Radix Peucedani 20 grams, Fructus Schisandrae Chinensis 30 grams, 30 grams, Colla Corii Asini, 30 grams, Semen sojae atricolor.Above various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.

Claims (1)

1. treat a Chinese medicine for deficiency of lung-YIN pattern of syndrome pneumonopathy, it is characterized in that the Chinese medicine preparation be made up of the medical material of following weight proportion: 25-30 parts, Rhizoma Zingiberis Recens, Succus Bambusae 15-20 parts, Radix Raphani 25-30 parts, Saccharum Sinensis Roxb. 25-30 parts, Borax 3-5 parts, Radix Sophorae Tonkinensis 10-12 parts, Flos Farfarae 15-20 parts, Cortex Phellodendri 8-10 parts, Radix Scrophulariae 12-15 parts, Radix Peucedani 15-20 parts, Fructus Schisandrae Chinensis 25-30 parts, 25-30 parts, Colla Corii Asini, 25-30 parts, Semen sojae atricolor.
CN201410556312.0A 2014-10-20 2014-10-20 Traditional Chinese medicine for treating lung yin deficiency syndrome type lung disease Pending CN104383470A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410556312.0A CN104383470A (en) 2014-10-20 2014-10-20 Traditional Chinese medicine for treating lung yin deficiency syndrome type lung disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410556312.0A CN104383470A (en) 2014-10-20 2014-10-20 Traditional Chinese medicine for treating lung yin deficiency syndrome type lung disease

Publications (1)

Publication Number Publication Date
CN104383470A true CN104383470A (en) 2015-03-04

Family

ID=52601494

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410556312.0A Pending CN104383470A (en) 2014-10-20 2014-10-20 Traditional Chinese medicine for treating lung yin deficiency syndrome type lung disease

Country Status (1)

Country Link
CN (1) CN104383470A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101406686A (en) * 2008-11-14 2009-04-15 宋冰 Medicament for mainly curing bronchial asthma and preparation method thereof
CN103330826A (en) * 2013-06-27 2013-10-02 柳晖 Traditional Chinese medicine composition for treating deficiency of lung yin
CN103860918A (en) * 2012-12-10 2014-06-18 马新福 Traditional Chinese medicine for treating lung deficiency-caused cough

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101406686A (en) * 2008-11-14 2009-04-15 宋冰 Medicament for mainly curing bronchial asthma and preparation method thereof
CN103860918A (en) * 2012-12-10 2014-06-18 马新福 Traditional Chinese medicine for treating lung deficiency-caused cough
CN103330826A (en) * 2013-06-27 2013-10-02 柳晖 Traditional Chinese medicine composition for treating deficiency of lung yin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
彭波: "中医药治疗肺阴虚证的研究进展", 《河北中医》 *
黄纯琪: "《中医常用辩证方法的临床应用》", 31 January 2013 *

Similar Documents

Publication Publication Date Title
CN103536889B (en) One is treated senile chronic tracheitis and is merged emophysematous Chinese medicine decoction
CN103055116B (en) Traditional Chinese medicine composition for treating acnes
CN103169904A (en) Traditional Chinese medicine composition for treating lung cancer
CN103933439A (en) Traditional Chinese medicine for treating chronic bronchitis
CN101757516A (en) Prescription of traditional Chinese medicine for treating infantile allergic asthma
CN106606719A (en) Traditional Chinese medicine used for treating chronic cough
CN105412877A (en) Traditional Chinese medicine preparation for treating influenza and preparation method thereof
CN104107344A (en) Traditional Chinese medicine composition for treating chronic bronchitis
CN103656457B (en) A kind of Chinese medicine for the treatment of insufficiency of lung-QI pattern of syndrome pneumonopathy
CN104383470A (en) Traditional Chinese medicine for treating lung yin deficiency syndrome type lung disease
CN104367827A (en) Traditional Chinese medicine for treating spleen-qi deficiency-weakness syndrome type somnolence
CN103656414B (en) A kind of Chinese medicine for the treatment of wind-heat invading the lung pattern of syndrome pneumonopathy
CN103520693B (en) Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris
CN103550662B (en) Traditional Chinese medicine for treating liver and stomach incoordination type distention and fullness
CN103007170B (en) Chinese medicinal composition for treating recurrent oral ulcer
CN103550431B (en) Traditional Chinese medicine for treating abdominal pain of syndrome of stagnation of liver qi and spleen deficiency
CN105327324A (en) Traditional Chinese medicine for treating cold-evil internal amassment type abdominal pain
CN106110244A (en) Powder for relieving cough and asthma
CN105687757A (en) Traditional Chinese medicine composition for treating phlegm-qi stagnation type hyperthyreosis with automatic junctional tachycardia
CN105056194A (en) Chinese herb composition for treating liver-qi stomach attacking and cold-heat mixed type chronic gastritis
CN103520675B (en) Traditional Chinese medicine for treating headache disease with symptom of fettering lung by wind-cold
CN105288174A (en) Traditional Chinese medicine for treating ulcerative colitis
CN104383303B (en) Traditional Chinese medicine composition for treating cerebral thrombosis
CN103550734A (en) Traditional Chinese medicine decoction for treating chronic bronchitis
CN103463444A (en) Traditional Chinese medicine composition for treating phlegm stagnation cross-resistance type acnes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150304